GlaxoSmithKline Pharmaceuticals Limited - Balance (Quarterly)

GlaxoSmithKline Pharmaceuticals Limited
IN ˙ NSEI ˙ INE159A01016
2.473,05 ₹ ↓ -18,35 (-0,74%)
2026-04-24
DEL PRIS
Balance (Quarterly)

GlaxoSmithKline Pharmaceuticals Limited Balance viser kontosaldi for virksomheden på tidspunkter. Balancedata inkluderer aktiver, omsætningsaktiver, anlægsaktiver, materielle anlægsaktiver (PPE), inventar, immaterielle aktiver, passiver, kortfristede forpligtelser, gæld, kapitalleasingforpligtelser, almindelige aktier, overført overskud, egne aktier og egenkapital.

Alle tal er gange 1,000,000.00 undtagen pr. andel enheder.

2021
09-30
2022
03-31
2022
09-30
2023
03-31
2023
09-30
2024
03-31
2024
09-30
2025
03-31
2025
09-30
Kontanter 11.891 2.862 7.567 349 10.913 642 11.100 5.388 7.478
Ændring (%) -75,93 164,40 -95,38 3.023,30 -94,12 1.629,76 -51,46 38,78
Aktiver Nuværende 21.810 37.080 21.954 24.943 24.994 27.984 30.144 34.099 29.713
Ændring (%) 70,01 -40,79 13,61 0,20 11,97 7,72 13,12 -12,86
Aktiver 30.539 46.333 30.153 33.266 32.702 35.566 37.460 41.081 36.651
Ændring (%) 51,71 -34,92 10,32 -1,69 8,76 5,32 9,67 -10,78
Forpligtelser 17.585 19.703 15.604 15.853 17.307 17.790 20.733 21.568 19.574
Ændring (%) 12,04 -20,81 1,60 9,17 2,79 16,54 4,03 -9,24
Egenkapital 12.954 26.630 14.549 17.413 15.396 17.776 16.727 19.513 17.077
Ændring (%) 105,57 -45,37 19,68 -11,58 15,46 -5,90 16,66 -12,48
Passiver og Aktiekapital 30.539 46.333 30.153 33.266 32.702 35.566 37.460 41.081 36.651
Ændring (%) 51,71 -34,92 10,32 -1,69 8,76 5,32 9,67 -10,78

Source: Capital IQ

Other Listings
IN:500660 2.473,05 ₹
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista